Sales opening

The industry applications for the EADV Symposium 2026 are open. 

To express your interest please contact [email protected]

Participation opportunities

Description

Onsite opportunity

virtual opportunity

Exhibition

Booth in the exhibition area

Onsite

VIRTUAL

-

Industry Sessions

All industry sessions have specific rules to be observed. Please refer to the respective catalogue.

Lunch Satellite Symposium on Thursday, 7 May 2026

Onsite

VIRTUAL

Lunch Satellite Symposium on Friday, 8 May 2026

Onsite

VIRTUAL

Advertisements

Venue advertisement spaces

Onsite

VIRTUAL

-

e-Blasts before, during and after the event

Onsite

-

VIRTUAL

Advertisements on the EADV industry sessions programme booklet

Onsite

-

VIRTUAL

Meeting Rooms

Meeting rooms at the congress centre

Onsite

VIRTUAL

-

EADV Symposium Platform

Company profile

Onsite

-

VIRTUAL

Sponsorship

HCP Scholarships

Onsite

VIRTUAL

Healthcare Professional definition

  1. Important note to Healthcare and Non-Healthcare Professionals

    Access to the different areas and sessions of the Symposium is determined by the attendee’s Healthcare Professional status.

    As a multidisciplinary audience will attend the EADV Congress, the EADV will assign different classes to Healthcare Professionals (HCPs) and Non-Healthcare Professionals (non-HCPs) to ensure compliance with the Hellenic Association of Pharmaceutical Companies (SFEE’s Promotion Code) (CODE OF ETHICS & PARTNERSHIPS | SFEE).
    Please read the description below to ensure that you (or your delegates) comply with the regulations in place.

EADV members are not automatically considered Healthcare Professionals

Please select the correct status (HCP or non-HCP) during registration.

  1. Definition The SFEE code defines Healthcare Professionals as follows (Definitions, page 6):“any natural person who is identified as a healthcare professional in the applicable legislation1 and whose primary practice or principal professional address is in Greece and who, in the course of his/her professional activities, may prescribe, purchase, supply, recommend or administer medicinal products.

    It is explicitly clarified that the very broad subset of Healthcare Professionals who are not legally entitled to prescribe, supply or administer medicinal products, but nevertheless belong to the category of Healthcare Professionals, are not considered as general public. In this sense, product promotions at scientific event venues where such persons may be present are no prohibited.

    In the context of the national cancer policy, the specialty of pathologists is also explicitly included in this definition.

    To avoid any doubt, the term“Healthcare Professional”, with the exception of Chapter 1

    hereof, also includes:

    1. any official or employee of a government agency or other organisation (whether in the public or private sector) who may prescribe, purchase, supply, recommend or administer Medicinal Products; and
    2. any employee of a Pharmaceutical Company whose primary occupation is that of a practising HCP (e.g. medical doctor, nurse, dentist, etc.).
    However, the definition excludes:
    • all other full-term personnel (whether HCPs or not) of a PC under an employment contract, professional service contract or independent work contract; and
    • wholesalers or distributors of Medicinal Products.”

    Article 4 of Law 4238/GG A, 38/17.02.2014, characterises the following persons as Healthcare Professionals (HCPs): family physicians and physicians of other specialties, dentists and other healthcare professionals such as midwives, health visitors, nurses, social workers, physiotherapists, dieticians/nutritionists, psychologists, occupational therapists, medical laboratory technologists, medical and biological laboratory assistants, medical equipment operators.

    Medical students are not considered Healthcare Professionals under the current guidelines and will be automatically classified as Non-Healthcare Professionals.

  1. Industry sessions

    Satellite Symposia presenting data on the development, research, or other issues related to prescription medicine is restricted to Healthcare Professionals and Non Member (INDUSTRY) as indicated by the Industry Session Organizer.
    All promotional materials and marketing aids related to these industry sessions should be strictly limited to HCPs.

    Industry Session organisers can limit participation to certain representative groups independently from the EADV recommendations if deemed imperative to achieving the session’s intended purpose. The organising company reserves the right to refuse single categories, particularly if they are not adequately related to the session’s objective and purpose.

    The industry session organiser is responsible for compliance with the session